vs

Side-by-side financial comparison of SUTRO BIOPHARMA, INC. (STRO) and STRATUS PROPERTIES INC (STRS). Click either name above to swap in a different company.

SUTRO BIOPHARMA, INC. is the larger business by last-quarter revenue ($11.6M vs $8.3M, roughly 1.4× STRATUS PROPERTIES INC). On growth, STRATUS PROPERTIES INC posted the faster year-over-year revenue change (-19.4% vs -21.4%). Over the past eight quarters, SUTRO BIOPHARMA, INC.'s revenue compounded faster (-5.4% CAGR vs -44.1%).

Sutro Biopharma, Inc. is a publicly traded biotechnology company headquartered in South San Francisco, California focused on clinical-stage drug discovery, development and manufacturing. Using a proprietary cell-free protein synthesis platform, Sutro is working on oncology therapeutics using protein engineering and rational design. Founded in 2003 under the name Fundamental Applied Biology, the company name changed to Sutro Biopharma in 2009. William Newell, CEO as of 2024, joined Sutro in Ja...

Ryman Hospitality Properties, Inc. is a hotel, resort, entertainment, and media company named for one of its assets: the Ryman Auditorium, a National Historic Landmark in Nashville, Tennessee. The company's legal lineage can be traced back to its time as a subsidiary of Edward Gaylord's Oklahoma Publishing Company; however, the backbone of the modern entity was formed with the company's acquisition of WSM, Inc. in 1983. This purchase resulted in the ownership of the Grand Ole Opry and associa...

STRO vs STRS — Head-to-Head

Bigger by revenue
STRO
STRO
1.4× larger
STRO
$11.6M
$8.3M
STRS
Growing faster (revenue YoY)
STRS
STRS
+1.9% gap
STRS
-19.4%
-21.4%
STRO
Faster 2-yr revenue CAGR
STRO
STRO
Annualised
STRO
-5.4%
-44.1%
STRS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
STRO
STRO
STRS
STRS
Revenue
$11.6M
$8.3M
Net Profit
$16.9M
Gross Margin
Operating Margin
Net Margin
203.2%
Revenue YoY
-21.4%
-19.4%
Net Profit YoY
35.4%
1293.4%
EPS (diluted)
$2.42

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
STRO
STRO
STRS
STRS
Q4 25
$11.6M
$8.3M
Q3 25
$9.7M
$5.0M
Q2 25
$63.7M
$11.6M
Q1 25
$17.4M
$5.0M
Q4 24
$14.8M
$10.3M
Q3 24
$8.5M
$8.9M
Q2 24
$25.7M
$8.5M
Q1 24
$13.0M
$26.5M
Net Profit
STRO
STRO
STRS
STRS
Q4 25
$16.9M
Q3 25
$-56.9M
$-8.0M
Q2 25
$-11.5M
$-2.3M
Q1 25
$-76.0M
$-3.8M
Q4 24
$-72.4M
$-1.4M
Q3 24
$-48.8M
$-1.4M
Q2 24
$-48.0M
$-2.8M
Q1 24
$-58.2M
$3.7M
Gross Margin
STRO
STRO
STRS
STRS
Q4 25
Q3 25
-85.1%
Q2 25
-19.0%
Q1 25
5.1%
Q4 24
18.3%
Q3 24
2.5%
Q2 24
10.9%
Q1 24
30.7%
Operating Margin
STRO
STRO
STRS
STRS
Q4 25
Q3 25
-499.9%
-162.9%
Q2 25
-5.2%
-6.5%
Q1 25
-393.8%
-71.3%
Q4 24
-440.7%
-13.6%
Q3 24
-797.2%
-17.1%
Q2 24
-189.4%
-34.4%
Q1 24
-435.0%
13.9%
Net Margin
STRO
STRO
STRS
STRS
Q4 25
203.2%
Q3 25
-586.6%
-161.1%
Q2 25
-18.0%
-19.8%
Q1 25
-436.6%
-74.5%
Q4 24
-489.2%
-13.7%
Q3 24
-572.6%
-15.9%
Q2 24
-186.8%
-32.7%
Q1 24
-447.5%
13.9%
EPS (diluted)
STRO
STRO
STRS
STRS
Q4 25
$2.42
Q3 25
$-0.67
$-0.62
Q2 25
$-0.14
$0.03
Q1 25
$-0.91
$-0.36
Q4 24
$-27.63
$-0.06
Q3 24
$-0.59
$-0.05
Q2 24
$-0.59
$-0.21
Q1 24
$-0.59
$0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
STRO
STRO
STRS
STRS
Cash + ST InvestmentsLiquidity on hand
$141.4M
$74.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$-132.5M
$204.5M
Total Assets
$173.8M
$563.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
STRO
STRO
STRS
STRS
Q4 25
$141.4M
$74.3M
Q3 25
$167.6M
$55.0M
Q2 25
$205.1M
$59.4M
Q1 25
$249.0M
$12.0M
Q4 24
$316.9M
$20.2M
Q3 24
$388.3M
$19.6M
Q2 24
$375.6M
$13.5M
Q1 24
$267.6M
$20.7M
Stockholders' Equity
STRO
STRO
STRS
STRS
Q4 25
$-132.5M
$204.5M
Q3 25
$-87.3M
$185.8M
Q2 25
$-32.1M
$191.9M
Q1 25
$-25.8M
$191.5M
Q4 24
$44.6M
$194.7M
Q3 24
$111.2M
$196.4M
Q2 24
$152.2M
$196.3M
Q1 24
$98.0M
$197.6M
Total Assets
STRO
STRO
STRS
STRS
Q4 25
$173.8M
$563.4M
Q3 25
$209.7M
$572.6M
Q2 25
$262.4M
$574.8M
Q1 25
$321.4M
$534.6M
Q4 24
$387.2M
$532.6M
Q3 24
$451.8M
$523.2M
Q2 24
$489.0M
$514.0M
Q1 24
$403.4M
$509.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
STRO
STRO
STRS
STRS
Operating Cash FlowLast quarter
$-177.2M
$-29.9M
Free Cash FlowOCF − Capex
$-38.0M
FCF MarginFCF / Revenue
-458.5%
Capex IntensityCapex / Revenue
98.2%
Cash ConversionOCF / Net Profit
-1.77×
TTM Free Cash FlowTrailing 4 quarters
$-70.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
STRO
STRO
STRS
STRS
Q4 25
$-177.2M
$-29.9M
Q3 25
$-38.2M
$-9.0M
Q2 25
$-44.7M
$-1.7M
Q1 25
$-67.9M
$-13.5M
Q4 24
$-71.7M
$-5.8M
Q3 24
$-64.5M
$-686.0K
Q2 24
$9.5M
$-8.3M
Q1 24
$-64.7M
$6.5M
Free Cash Flow
STRO
STRO
STRS
STRS
Q4 25
$-38.0M
Q3 25
$-9.9M
Q2 25
$-4.3M
Q1 25
$-18.0M
Q4 24
$-35.0M
Q3 24
$-7.5M
Q2 24
$-16.3M
Q1 24
$-1.6M
FCF Margin
STRO
STRO
STRS
STRS
Q4 25
-458.5%
Q3 25
-198.7%
Q2 25
-37.2%
Q1 25
-357.4%
Q4 24
-339.7%
Q3 24
-84.4%
Q2 24
-191.6%
Q1 24
-6.0%
Capex Intensity
STRO
STRO
STRS
STRS
Q4 25
98.2%
Q3 25
18.4%
Q2 25
22.7%
Q1 25
89.8%
Q4 24
283.0%
Q3 24
76.7%
Q2 24
94.2%
Q1 24
30.7%
Cash Conversion
STRO
STRO
STRS
STRS
Q4 25
-1.77×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
1.77×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons